Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment-Reference-Cited by-同舟云学术

Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment

Published:2020-05-01 Issue:9 Volume:59 Page:1199-1202
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nakashima Kei¹,Saruwatari Koichi¹,Sato Ryo¹,Imamura Kosuke¹,Kajihara Ikko²,Fukushima Satoshi²,Saito Tetsuo³,Ishizuka Shiho¹,Tamanoi Daisuke¹,Jodai Takayuki¹,Hamada Shohei¹,Tomita Yusuke¹,Saeki Sho¹,Ichiyasu Hidenori¹,Oya Natsuo³,Ihn Hironobu²,Sakagami Takuro¹

Affiliation:

1. Department of Respiratory Medicine, Kumamoto University Hospital, Japan

2. Department of Dermatology and Plastic Surgery, Kumamoto University Hospital, Japan

3. Department of Radiation Oncology, Kumamoto University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/9/59_3937-19/_pdf

Reference14 articles.

1. 1. Facchinetti F, Bordi P, Leonetti A, Buti S, Tiseo M. Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives. Drug Des Devel Ther 12: 2857-2873, 2018.

2. 2. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. New Engl J Med 378: 158-168, 2018.

3. 3. Haanen J, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28 (Suppl 4): iv119-iv142, 2017.

4. 4. Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J clinical oncology: official journal of the American Society of Clinical Oncology 36: 1714-1768, 2018.

5. 5. Lacouture M, Sibaud V. Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol 19 (Suppl 1): 31-39, 2018.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical evidence for synergy between immunotherapy and radiotherapy ( SITAR );Journal of Medical Imaging and Radiation Oncology;2022-06-14

2. Mesenchymal Stem Cells and their Derived Exosomes Promote Malignant Phenotype of Polyploid Non-Small-Cell Lung Cancer Cells through AMPK Signaling Pathway;Analytical Cellular Pathology;2022-04-04

3. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy;Radiation Oncology;2022-03-09

4. Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature Review;Cureus;2021-06-09

5. Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report;Respiratory Medicine Case Reports;2021